Protease-activated receptor-2 (PAR-2): Structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes

被引:48
|
作者
Maryanoff, BE [1 ]
Santulli, RJ [1 ]
McComsey, DF [1 ]
Hoekstra, WJ [1 ]
Hoey, K [1 ]
Smith, CE [1 ]
Addo, M [1 ]
Darrow, AL [1 ]
Andrade-Gordon, P [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Drug Discovery, Spring House, PA 19477 USA
关键词
protease-activated receptor; agonist peptides; intracellular calcium; structure-activity; tethered-ligand receptor; transfected cells;
D O I
10.1006/abbi.2000.2207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated receptor-a (PAR-S) is a tethered-ligand, G-protein-coupled receptor that is activated by proteolytic cleavage or by small peptides derived from its cleaved N-terminal sequence, such as SLIGRL-NH2. To assess specific PAR activity, we developed an immortalized murine PAR-1 (-/-) cell line transfected with either human PAR-8 or PAR-1. A "directed" library of more than 100 PAR agonist peptide analogues was synthesized and evaluated for PAR-8 and PAR-1 activity to establish an in-depth structure-function profile for specific action on PAR-S. The most potent agonist peptides (EC50 = 2-4 muM) had Lys at position 6, Ala at position 4, and pFPhe at position 2; however, these also exhibited potent PAR-1 activity (EC50 = 0.05-0.35 muM). We identified SLIARK-NH2 and SL-Cha-ARL-NH2 as relatively potent, highly selective PAR-2 agonists with EC50 values of 4 muM. Position 1 did not tolerate basic, acidic, or large hydrophobic amino acids. N-Terminal capping by acetyl eliminated PAR-2 activity, although removal of the amino group reduced potency by just 4-fold. At position 2, substitution of Leu by Cha or Phe gave equivalent PAR-2 potency, but this modification also activated PAR-1, whereas Ala, Asp, Lys, or Gln abolished PAR-2 activity; at position 3, Re and Cha were optimal, although various amino acids were tolerated; at position 4, Ala or Cha increased PAR-2 potency 2-fold, although Cha introduced PAR-1 activity; at position 5, Arg or Lys could be replaced successfully by large hydrophobic amino acids. These results with hexapeptide C-terminal amides that mimic the native PAR-2 ligand indicate structural modes for obtaining optimal PAR-2 activity, which could be useful for the design of PAR-2 antagonists. (C) 2001 Academic Press.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 50 条
  • [31] Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells
    Molino, M
    Raghunath, PN
    Kuo, A
    Ahuja, M
    Hoxie, JA
    Brass, LF
    Barnathan, ES
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) : 825 - 832
  • [32] Role of tissue factor (TF)/protease-activated receptor-2 (PAR-2) signaling in pancreatic cancer progression
    Chang, Li-Hsun
    Pan, Shiow-Lin
    Teng, Che-Ming
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 4 - 4
  • [33] Neutrophil Extracellular Traps (NETs), Protease-Activated receptor-2 (PAR-2) and Fibrosis in Hodgkin's Lymphoma
    Francischetti, Ivo
    Alejo, Julie
    Davies-Hill, Theresa
    Jaffe, Elaine
    Pittaluga, Stefania
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1286 - 1286
  • [34] Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix
    Gruber, BL
    Marchese, MJ
    Santiago-Schwarz, F
    Martin, CA
    Zhang, JH
    Kew, RR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (05) : 832 - 839
  • [35] Protease-activated receptor-2 (PAR-2)-mediated increase in neutrophil adhesion to alveolar epithelial cells.
    Yagi, Y
    Otani, H
    Oshiro, A
    Inagaki, C
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 251P - 251P
  • [36] Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: Correlation with clinicopathological features and prognosis
    Li, Zhi
    Bian, Li-Juan
    Li, Yang
    Liang, Ying-Jie
    Liang, Hui-Zhen
    PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (08) : 542 - 550
  • [37] Exogeneous chitinases activate and induce degranulation of human eosinophils through a protease-activated receptor-2 (PAR-2)
    Matsuwaki, Y
    Thomas, W
    Hotta, K
    Kita, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S189 - S189
  • [38] Cockroach allergen extract stimulates protease-activated receptor-2 (PAR-2) expressed in mouse lung fibroblast
    Kondo, S
    Helin, H
    Shichijo, M
    Bacon, KB
    INFLAMMATION RESEARCH, 2004, 53 (09) : 489 - 496
  • [39] Neutrophil Extracellular Traps (NETs), Protease-Activated receptor-2 (PAR-2) and Fibrosis in Hodgkin's Lymphoma
    Francischetti, Ivo
    Alejo, Julie
    Davies-Hill, Theresa
    Jaffe, Elaine
    Pittaluga, Stefania
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1286 - 1286
  • [40] Cockroach allergen extract stimulates protease-activated receptor-2 (PAR-2) expressed in mouse lung fibroblast
    S. Kondo
    H. Helin
    M. Shichijo
    K. B. Bacon
    Inflammation Research, 2004, 53 : 489 - 496